CENICRIVIROC FOR THE TREATMENT OF HIV-2 INFECTION

• 收藏
• 分享

专利权人:

发明人:

Eric LEFEBVRE

申请号：

US15315477

公开号：

US20170105969A1

申请日:

2015.06.02

申请国别(地区):

US

年份:

2017

代理人:

摘要：

Cenicriviroc (CVC) is an orally active antagonist of ligand binding to C—C chemokine receptor type 5 (CCR5) and C—C chemokine receptor type 2 (CCR2). CVC blocks the binding of RANTES, MIP-1α, and MIP-1β to CCR5, and of MCP-1/CCL2 to CCR2. Methods of treating HIV-2 infection and related conditions comprising administration of CVC are provided herein.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/